“Michael is a strategic-minded, results-oriented leader with an entrepreneurial mindset. With his vast healthcare experience in legal, regulatory compliance and operations, Michael will be an extremely value-added team member to our current and future healthcare investments,” said David Kessenich, Managing Partner and Co-Founder of Excellere Partners.
Most recently, Mr. Geldart was the Chief Operating Officer of BioTelemetry, a provider of cardiac monitoring, cardiac monitoring device manufacturing, and cardiac laboratory services. Before joining BioTelemetry in 2012, he was the Chief Operating Officer of MedExpress, a multi-state urgent care provider and a former portfolio company of Excellere Partners. Before MedExpress, he was the Chief Operating Officer and EVP of Corporate Development of CCS Medical, a provider of medical and pharmacy supplies for patients suffering from diabetes, respiratory and other chronic conditions.
This is the third partner addition for Excellere in the past month. In late October the firm promoted Brad Cornell and Ryan Glaws to Partner.
Excellere invests in middle-market companies with revenues ranging from $20 million to $150 million. Sectors of interest include healthcare services and products; energy and utility products and services; industrial technology and services; business services; and agri-business. The firm has $1.4 billion of capital under management and is based in Denver (www.excellerepartners.com).
© 2015 PEPD • Private Equity’s Leading News Magazine • 11-20-15